"What Is the Best Treatment Approach for Stage IIIB Lung Cancer?"

Update Date: Source: Network

Lung Cancer Stage IIIB

Lung cancer Stage IIIB typically refers to non-small cell lung cancer (NSCLC) in its Stage IIIB form. Treatment for early-stage NSCLC IIIB involves surgical resection, while for late-stage NSCLC IIIB, control of the disease through chemotherapy, targeted drug therapy, and other methods is necessary.

Early-Stage NSCLC IIIB

1. Surgical Resection: If the patient's tumor is small and has not metastasized distantly, surgical options such as segmentectomy or lobectomy can be performed to achieve radical treatment goals.

2. Chemotherapy: Post-surgery, adjuvant chemotherapy with cisplatin injection, carboplatin injection, and other chemotherapeutic agents may be administered to inhibit cancer cell proliferation and prevent recurrence.

Late-Stage NSCLC IIIB

1. Targeted Drug Therapy: For patients who are unable to tolerate surgery due to poor physical condition, targeted therapies like gefitinib tablets and erlotinib hydrochloride tablets can be prescribed to effectively inhibit cancer cell growth and proliferation, thereby prolonging survival time.

2. Radiotherapy: In conjunction with radiotherapy, high-energy rays can be used to irradiate local tissues, killing cancer cells and alleviating symptoms.

Additionally, maintaining a healthy diet in daily life is crucial. It is recommended to consume light foods like millet porridge and corn porridge, avoiding spicy, irritating, raw, or cold foods, as these may hinder recovery. If any significant discomfort arises during this period, prompt medical attention is advised to prevent disease progression.